Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Change in Account Payables (2022 - 2026)

Core Laboratories filings provide 5 years of Change in Account Payables readings, the most recent being $2.8 million for Q1 2026.

  • On a quarterly basis, Change in Account Payables fell 4.17% to $2.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $353000.0, a 91.26% decrease, with the full-year FY2025 number at $477000.0, down 8.09% from a year prior.
  • Change in Account Payables hit $2.8 million in Q1 2026 for Core Laboratories, up from -$807000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $11.1 million in Q4 2022 to a low of -$7.1 million in Q1 2023.
  • Median Change in Account Payables over the past 5 years was -$551000.0 (2024), compared with a mean of $85133.3.
  • Biggest five-year swings in Change in Account Payables: crashed 470.54% in 2023 and later surged 639.2% in 2025.
  • Core Laboratories' Change in Account Payables stood at $11.1 million in 2022, then tumbled by 97.99% to $223000.0 in 2023, then soared by 300.0% to $892000.0 in 2024, then crashed by 190.47% to -$807000.0 in 2025, then soared by 452.79% to $2.8 million in 2026.
  • The last three reported values for Change in Account Payables were $2.8 million (Q1 2026), -$807000.0 (Q4 2025), and -$5.4 million (Q3 2025) per Business Quant data.